8-heteroaryl xanthine adenosine A2B receptor antagonists

Details for Australian Patent Application No. 2003214982 (hide)

Owner KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.

Inventors Baraldi, Pier Giovanni; Borea, Pier A.

Agent Pizzeys

Pub. Number AU-A-2003214982

PCT Number PCT/US03/03224

PCT Pub. Number WO2003/063800

Priority 60/353,317 01.02.02 US

Filing date 3 February 2003

Wipo publication date 2 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/353,317 01.02.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003214982

28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214983-Chimeric bird from embryonic stem cells

2003214981-MOLECULAR HEPATOTOXICOLOGY MODELING